BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12938523)

  • 1. Perioperative cimetidine application modulates natural killer cells in patients with colorectal cancer: a randomized clinical study.
    Bai D; Yang G; Yuan H; Li Y; Wang K; Shao H
    J Tongji Med Univ; 1999; 19(4):300-3. PubMed ID: 12938523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial.
    Lin CY; Bai DJ; Yuan HY; Wang K; Yang GL; Hu MB; Wu ZQ; Li Y
    World J Gastroenterol; 2004 Jan; 10(1):136-42. PubMed ID: 14695785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of perioperative cimetidine administration on peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: results of a randomized controlled clinical trial.
    Li Y; Yang GL; Yuan HY; Bai DJ; Wang K; Lin CR; Hu MB; Feng MH
    Hepatogastroenterology; 2005; 52(62):504-8. PubMed ID: 15816467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative cimetidine administration improves systematic immune response and tumor infiltrating lymphocytes in patients with colorectal cancer.
    Li B; Cao F; Zhu Q; Li B; Gan M; Wang D
    Hepatogastroenterology; 2013; 60(122):244-7. PubMed ID: 22944376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine reduces impairment of cellular immunity after cardiac operations with cardiopulmonary bypass.
    Katoh J; Tsuchiya K; Osawa H; Sato W; Matsumura G; Iida Y; Suzuki S; Hosaka S; Yoshii S; Tada Y
    J Thorac Cardiovasc Surg; 1998 Aug; 116(2):312-8. PubMed ID: 9699585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cimetidine preserves non-specific immune function after colonic resection for cancer.
    Adams WJ; Morris DL; Ross WB; Lubowski DZ; King DW; Peters L
    Aust N Z J Surg; 1994 Dec; 64(12):847-52. PubMed ID: 7980260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented natural killer activity in ovarian cancer patients treated with cimetidine.
    Kikuchi Y; Oomori K; Kizawa I; Kato K
    Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1037-43. PubMed ID: 3780810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cimetidine modulates natural killer cell function of patients with chronic lymphocytic leukemia.
    Allen JI; Syropoulos HJ; Grant B; Eagon JC; Kay NE
    J Lab Clin Med; 1987 Apr; 109(4):396-401. PubMed ID: 3493314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of cimetidine with 5-fluorouracil and folinic acid in metastatic colorectal cancer.
    Links M; Clingan PR; Phadke K; O'Baugh J; Legge J; Adams WJ; Ross WB; Morris DL
    Eur J Surg Oncol; 1995 Oct; 21(5):523-5. PubMed ID: 7589598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mistletoe extract reduces the surgical suppression of natural killer cell activity in cancer patients. a randomized phase III trial.
    Schink M; Tröger W; Dabidian A; Goyert A; Scheuerecker H; Meyer J; Fischer IU; Glaser F
    Forsch Komplementmed; 2007 Feb; 14(1):9-17. PubMed ID: 17341882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of cimetidine mainly increases CD4+ cells of peripheral blood T lymphocytes].
    Asakage M; Tsuno NH; Kitayama J; Yamada J; Tsuchiya T; Yoneyama S; Takahashi K; Nagawa H
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1576-7. PubMed ID: 16315874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible association of decreased NKG2D expression levels and suppression of the activity of natural killer cells in patients with colorectal cancer.
    Shen Y; Lu C; Tian W; Wang L; Cui B; Jiao Y; Ma C; Ju Y; Zhu L; Shao C; Liu X; Wang J; Zhang B; Lu Z
    Int J Oncol; 2012 Apr; 40(4):1285-90. PubMed ID: 22200673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of curative surgery on natural killer cell activity in colorectal cancer.
    Espí A; Arenas J; García-Granero E; Martí E; Lledó S
    Dis Colon Rectum; 1996 Apr; 39(4):429-34. PubMed ID: 8878504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of essential fatty acids on natural cytotoxicity in patients with colorectal cancer.
    Purasiri P; Ashby J; Heys SD; Eremin O
    Eur J Surg Oncol; 1995 Jun; 21(3):254-60. PubMed ID: 7781792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of liver metastases through perioperative acute CpG-C immune stimulation.
    Sorski L; Melamed R; Levi B; Matzner P; Lavon H; Rosenne E; Shaashua L; Ricon I; Sandbank E; Benbenishty A; Ben-Eliyahu S
    Cancer Immunol Immunother; 2020 Oct; 69(10):2021-2031. PubMed ID: 32405793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients.
    Kubota T; Fujiwara H; Ueda Y; Itoh T; Yamashita T; Yoshimura T; Okugawa K; Yamamoto Y; Yano Y; Yamagishi H
    Br J Cancer; 2002 Apr; 86(8):1257-61. PubMed ID: 11953882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer (NK) cell activity of mice treated with herpes simplex virus type-2, sarcoma-180 cells, cyclosporine and cimetidine.
    Kabuta H; Tanaka M; Noda Y; Yamamoto S; Shingu M
    Kurume Med J; 1990; 37(4):229-34. PubMed ID: 1965843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-course cimetidine and survival with colorectal cancer.
    Adams WJ; Morris DL
    Lancet; 1994 Dec 24-31; 344(8939-8940):1768-9. PubMed ID: 7997018
    [No Abstract]   [Full Text] [Related]  

  • 19. Peripheral Foxp3+ regulatory T cells and natural killer group 2, member D expression levels in natural killer cells of patients with colorectal cancer.
    Shen Y; Wang Q; Qi Y; Cui B; Zhang Z; Su J; Liu X; Lu C; Ye H; Ju Y; Lu Z
    Mol Med Rep; 2014 Aug; 10(2):977-82. PubMed ID: 24819058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy.
    Cui F; Qu D; Sun R; Nan K
    Med Oncol; 2019 Sep; 36(10):84. PubMed ID: 31493232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.